Extranodal Lymphoma — Trials

Extranodal Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 13%
Top sponsor: Ruijin Hospital
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06069830	PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma(ENKTL)	recruiting	N/A	89	Ruijin HospitalOTHER	1	Jan 27, 2026	clinicaltrials
NCT05662540	PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma	recruiting	N/A	40	Ruijin HospitalOTHER	1	Oct 26, 2024	clinicaltrials